Correlation Between Australia and Actinogen Medical

Can any of the company-specific risk be diversified away by investing in both Australia and Actinogen Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Australia and Actinogen Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Australia and New and Actinogen Medical, you can compare the effects of market volatilities on Australia and Actinogen Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Australia with a short position of Actinogen Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Australia and Actinogen Medical.

Diversification Opportunities for Australia and Actinogen Medical

-0.04

Correlation Coefficient

Australia  Actinogen Medical

Good diversification

The 3 months correlation between Australia and Actinogen is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Australia and New and Actinogen Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinogen Medical and Australia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Australia and New are associated (or correlated) with Actinogen Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinogen Medical has no effect on the direction of Australia i.e., Australia and Actinogen Medical go up and down completely randomly.

Pair Corralation between Australia and Actinogen Medical

Assuming the 90 days trading horizon Australia and New is expected to under-perform the Actinogen Medical. But the stock apears to be less risky and, when comparing its historical volatility, Australia and New is 3.67 times less risky than Actinogen Medical. The stock trades about -0.04 of its potential returns per unit of risk. The Actinogen Medical is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  2.70  in Actinogen Medical on October 22, 2024 and sell it today you would lose (0.20) from holding Actinogen Medical or give up 7.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Australia and New  vs.  Actinogen Medical

Australia and New

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Australia and New has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Australia is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Actinogen Medical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Actinogen Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Australia and Actinogen Medical

The main advantage of trading using opposite Australia and Actinogen Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Australia position performs unexpectedly, Actinogen Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will offset losses from the drop in Actinogen Medical's long position.

The idea behind Australia and New and Actinogen Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.